HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Leitão, A. Articles by Martins, C. L. V. Search for Related Content PubMed PubMed Citation Articles by Leitão, A. Articles by Martins, C. L. V. Agricola Articles by Leitão, A. Articles by Martins, C. L. V.

The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response

Laboratório de Doenças Infecciosas, CIISA, Faculdade de Medicina Veterinária, Rua Professor Cid dos Santos, 1300-477 Lisbon, Portugal¹
Centro de Veterinária e Zootecnia, CIISA, Instituto de Investigação Científica Tropical, Rua Professor Cid dos Santos, 1300-477 Lisbon, Portugal²
Departamento de Virologia, Laboratório Nacional de Investigação Veterinária, Estrada de Benfica 701, 1549-011 Lisbon, Portugal³
Instituto Gulbenkian de Ciência, Rua da Quinta Grande 6, 2780-156 Oeiras, Portugal⁴

Author for correspondence: Carlos L. V. Martins. Fax +351 21 365 28 21. e-mail cmartins{at}fmv.utl.pt

African swine fever virus ASFV/NH/P68 is a naturally occurring, non-haemadsorbing and non-fatal isolate. Longitudinal clinical and immunological studies on 31 pigs inoculated oronasally or intramuscularly with this isolate defined two discrete groups of animals: those developing ASF chronic type lesions and those remaining asymptomatic. Animals developing lesions had viraemia and fever late after infection, NK activity levels close to that of control animals and high levels of anti-ASFV specific antibodies together with a marked hypergammaglobulinaemia involving IgG1, IgG2, IgM and IgA immunoglobulin isotypes. Pigs remaining asymptomatic after infection, on the other hand, did not have viraemia or fever after day 14 post-infection and had elevated NK cell activity, but normal plasma Ig concentrations and relatively low specific anti-virus antibody concentrations throughout the duration of the experiments. Importantly, the latter group of pigs virus were resistant to subsequent challenge with the highly virulent ASFV/L60 isolate and survived with no major changes in any of the parameters examined and referred to above. Finally, lymphoproliferative responses to the mitogens concanavalin A, phytohaemagglutinin and pokeweed mitogen were not depressed in either of the two clinically defined groups of pigs. Thus further studies with this infection model may provide new insights on mechanisms of protective immunity to ASFV.

This article has been cited by other articles:

				C. Gallardo, A. L. Reis, G. Kalema-Zikusoka, J. Malta, A. Soler, E. Blanco, R. M. E. Parkhouse, and A. Leitao Recombinant Antigen Targets for Serodiagnosis of African Swine Fever Clin. Vaccine Immunol., July 1, 2009; 16(7): 1012 - 1020. [Abstract] [Full Text] [PDF]

				A. L. Reis, R. M. E. Parkhouse, A. R. Penedos, C. Martins, and A. Leitao Systematic analysis of longitudinal serological responses of pigs infected experimentally with African swine fever virus J. Gen. Virol., September 1, 2007; 88(9): 2426 - 2434. [Abstract] [Full Text] [PDF]

				C. L. Netherton, M.-C. McCrossan, M. Denyer, S. Ponnambalam, J. Armstrong, H.-H. Takamatsu, and T. E. Wileman African Swine Fever Virus Causes Microtubule-Dependent Dispersal of the trans-Golgi Network and Slows Delivery of Membrane Protein to the Plasma Membrane J. Virol., November 15, 2006; 80(22): 11385 - 11392. [Abstract] [Full Text] [PDF]

				F. Zhang, P. Hopwood, C. C. Abrams, A. Downing, F. Murray, R. Talbot, A. Archibald, S. Lowden, and L. K. Dixon Macrophage Transcriptional Responses following In Vitro Infection with a Highly Virulent African Swine Fever Virus Isolate. J. Virol., November 1, 2006; 80(21): 10514 - 10521. [Abstract] [Full Text] [PDF]

				A. P. Basto, R. J. Nix, F. Boinas, S. Mendes, M. J. Silva, C. Cartaxeiro, R. S. Portugal, A. Leitao, L. K. Dixon, and C. Martins Kinetics of African swine fever virus infection in Ornithodoros erraticus ticks J. Gen. Virol., July 1, 2006; 87(7): 1863 - 1871. [Abstract] [Full Text] [PDF]

				C. A. L. Oura, M. S. Denyer, H. Takamatsu, and R. M. E. Parkhouse In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus J. Gen. Virol., September 1, 2005; 86(9): 2445 - 2450. [Abstract] [Full Text] [PDF]